How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Collagen Biomaterial Market
- By Source Type: Bovine Collagen, Porcine Collagen, Marine Collagen, Avian Collagen, Recombinant Human Collagen
- By Form: Powder, Gel, Film, Membrane, Solution
- By Application: Wound Care, Tissue Engineering, Drug Delivery, Cosmetic Surgery, Orthopedic Surgery
- By End-Use Industry: Pharmaceuticals, Medical Devices, Cosmetics, Food & Beverages, Nutraceuticals
- By Purity Grade: Medical Grade, Food Grade, Cosmetic Grade
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Bovine Collagen leads By Source Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 13 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.183 →
- 12 Company Profiles 13 players: SWOT & benchmarking p.191 →
Full report · locked preview
Everything inside the Collagen Biomaterial Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 13 company profiles, forecast to 2033.
Segmentation covered
Source Type 5
Form 5
Application 5
End-Use Industry 5
Purity Grade 3
Companies profiled
Rousselot
Gelita AG
Nitta Gelatin Inc.
Weishardt Group
PB Gelatins GmbH
Collagen Solutions plc
Kewpie Corporation
Nippi Collagen Industries Inc.
Darling Ingredients Inc.
Juncai Group
Gelnex Inc.
Capsugel (Lonza Group)
+1 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
13 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Rousselot
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Gelita AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Nitta Gelatin Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Weishardt Group
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →PB Gelatins GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Collagen Solutions plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Kewpie Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Nippi Collagen Industries Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Darling Ingredients Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Juncai Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Gelnex Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Capsugel (Lonza Group)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →GELITA AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,329M by 2033 · 7.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Bovine Collagen42.1
- Porcine Collagen16.1
- Marine Collagen10.3
- Avian Collagen15.4
- Recombinant Human Collagen16.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$827.5M → $1,590M · 8.5%
Europe$576.8M → $1,103M · 8.4%
Asia Pacific$526.6M → $1,014M · 8.5%
Latin America$326.0M → $601.2M · 8.0%
Middle East and Africa$250.8M → $484.0M · 8.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.012026
7.022027
7.042028
7.062029
7.052030
7.072031
7.102032
7.102033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Rousselot20.0
- Gelita AG18.3
- Nitta Gelatin Inc.11.4
- Weishardt Group11.7
- PB Gelatins GmbH6.2
- Collagen Solutions plc4.3
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Source Type18.4%
Form23.2%
Application27.4%
End-Use Industry18.7%
Purity Grade12.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.2
- Europe23.0
- Asia Pacific21.2
- Latin America12.5
- Middle East and Africa10.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Rousselot | 87 | 86 | 93 | 82 | 78 | 75 | 84 |
| Gelita AG | 82 | 85 | 75 | 88 | 68 | 83 | 80 |
| Nitta Gelatin Inc. | 81 | 64 | 63 | 76 | 66 | 78 | 71 |
| Weishardt Group | 80 | 73 | 68 | 75 | 78 | 64 | 73 |
| PB Gelatins GmbH | 58 | 61 | 68 | 73 | 54 | 71 | 64 |
| Collagen Solutions plc | 61 | 66 | 59 | 46 | 55 | 54 | 57 |
| Kewpie Corporation | 59 | 66 | 44 | 58 | 64 | 59 | 58 |
| Nippi Collagen Industries Inc. | 58 | 47 | 44 | 40 | 51 | 36 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Rousselot
- Gelita AG
- Nitta Gelatin Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Rousselot | ✓ | ✓ | ✓ | ✓ | ◐ | ◐ |
| Gelita AG | ✓ | ◐ | ◐ | ◐ | ✓ | ◐ |
| Nitta Gelatin Inc. | ◐ | ◐ | ◐ | ◐ | ✓ | ◐ |
| Weishardt Group | ◐ | − | ◐ | ◐ | ✓ | ◐ |
| PB Gelatins GmbH | ◐ | − | ◐ | ◐ | − | ◐ |
| Collagen Solutions plc | − | ◐ | ◐ | − | ◐ | − |
| Kewpie Corporation | ◐ | − | − | ◐ | − | ◐ |
| Nippi Collagen Industries Inc. | ◐ | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Rousselot84
2Gelita AG80
3Weishardt Group73
4Nitta Gelatin Inc.71
5PB Gelatins GmbH64
6Kewpie Corporation58
7Collagen Solutions plc57
8Nippi Collagen Industries Inc.46
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
RousselotGelita AG
Challenger2
Strong scale, closing on the leaders.
Nitta Gelatin Inc.Weishardt Group
Contender3
Focused players with pockets of strength.
PB Gelatins GmbHCollagen Solutions plcKewpie Corporation
Niche1
Specialists in a single segment or region.
Nippi Collagen Industries Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Source Type in North America, then scale across Collagen Biomaterial Market — a $133M beachhead inside a $2.05B market.
Beachhead (SOM)$133Mobtainable near-term
Serviceable (SAM)$822Mreachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Bovine Collagen
Best fit — highest urgency & budget in Source Type.
Economic buyer79 fit
Porcine Collagen
Strong fit — clear ROI and a fast path to value.
End user69 fit
Marine Collagen
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Source Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Form & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel28%
Digital / self-serve20%
Marketplaces10%
Positioning & messaging
§GTM 2 · p.194 →For Source Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Collagen Biomaterial Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified38%
Sales qualified20%
Evaluation14%
Closed-won6%
$10.6KCAC
$58KLTV
5.5:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Collagen Biomaterial Market is a resilient opportunity — $3.04B by 2033, compounding at 4.2%.
TAM · 2025$2.19Btoday
TAM · 2033$3.04Bforecast
CAGR4.2%2027–2033
Cumulative$23.3Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$3.04BTotal addressable market
SAM$1.18BServiceable available market
SOM$190MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.2% CAGR
Demand compounds through 2033, outpacing GDP across Source Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Source Type moving from early to mainstream — durable secular demand.
Consolidation upside
13+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$3.04BLarge & growingTAM by 2033 at 4.2% CAGR
$1.18BServiceable nowreachable with today’s model
$190MBeachhead winobtainable near-term share
13+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.37BBear2.7% CAGR
$3.04BBase4.2% CAGR
$3.89BBull5.5% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Form optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Collagen Biomaterial Market — a $6.80B market by 2033. Plan: grow share from 7.5% to 13.5%.
Market size · 2033$6.80Btotal addressable
Market CAGR10.3%2027–2033
Target share13.5%from 7.5% today
Revenue ambition$918Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.5% | 13.5% | On track |
| Revenue | $549M | $918M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 35.3% | 42.4% | Behind |
| Customer retention | 87.4% | 96.1% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Source Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Form capability
A defensible second engine — invest in Form to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Source Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Form
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $127M capacity & capability investment
- Greenlight bolt-on M&A in Form
- Authorise North America expansion plan
- Fund R&D program for Source Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Collagen Biomaterial Market conversation — a $7.72B market you can size, segment and defend in minutes.
Market size · 2033$7.72Btotal opportunity
Growth7.7%CAGR to 2033
Addressable buyers1,722+accounts in scope
Typical ROI7.2×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Source Type
Goal Grow share in Source Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.2×return on cost, year one
< 3 mopayback period
$54K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
13+players profiled in this market
Coverage includes
RousselotGelita AGNitta Gelatin Inc.Weishardt GroupPB Gelatins GmbHCollagen Solutions plcKewpie CorporationNippi Collagen Industries Inc.+5 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Collagen Biomaterial Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Collagen Biomaterial Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Liver Health Supplements Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportKidney/Renal Cancer Drugs Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportEndodontic Calcium Hydroxide Material Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportTest Boosters Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportTrial Size Supplements Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportStimulant-Free Fat Burners Market
Market size, share, segmentation and regional forecast.
$560M market · 2025 base year
View reportMedical Decision Support Systems for Sepsis Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportPharma-grade Synthetic Camphor Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportHGH Biosimilars Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportHepatocellular Carcinoma Drug Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportWhole Cell Cholera Vaccine Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportAir Polishing Device Market
Market size, share, segmentation and regional forecast.
$719M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.